Kawasumi Laboratories Inc. announced consolidated earnings results for the six months ended September 30, 2017. For the period, the company reported net sales of ¥12,567 million against ¥12,287 million a year ago. Operating profit was ¥342 million against ¥571 million a year ago. Ordinary profit was ¥444 million against ¥467 million a year ago. Profit before income taxes was ¥427 million against ¥465 million a year ago. Profit attributable to owners of parent was ¥313 million against ¥636 million a year ago. Earnings per share were ¥14.37 against ¥29.16 a year ago. Net cash provided by operating activities was ¥1,388 million against ¥1,765 million a year ago. Purchase of property, plant and equipment was ¥420 million against ¥743 million a year ago. Purchase of intangible assets was ¥21 million against ¥120 million a year ago.

For the full year of fiscal year ending March 31, 2018, the company expects consolidated net sales of ¥25,000 million, operating income of ¥650 million, ordinary income of ¥600 million, profit attributable to owners of the parent of ¥600 million or earnings per share of ¥27.50.